Literature DB >> 16464715

Prognostic value of cardiac I-123 metaiodobenzylguanidine imaging in patients with non-insulin-dependent diabetes mellitus.

Shigeki Nagamachi1, Seigo Fujita, Ryuichi Nishii, Shigemi Futami, Shozo Tamura, Masanari Mizuta, Masamitsu Nakazato, Takeshi Kurose, Hideyuki Wakamatsu.   

Abstract

BACKGROUND: 123I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy is a useful tool for diagnosing cardiac autonomic neuropathy (CAN) in non-insulin-dependent diabetes mellitus (NIDDM). However, the long-term prognostic value for cardiac events or mortality in NIDDM has not been clarified. METHODS AND
RESULTS: We investigated the long-term prognostic value of cardiac MIBG imaging for both cardiac event and mortality owing to a variety of causes of death in NIDDM. 144 NIDDM patients were analyzed retrospectively with the end-points of a cardiac event and various causes of mortality. The heart-to-mediastinum uptake ratio on the delayed image (H/M [d]) was obtained from anterior planar imaging. The mean follow-up period was 7.2+/-3.2 years. Seventeen patients had a cardiac event onset and 7 patients died during observation. During the same observation course, 16 patients died, including some who died of cardiac event. Both multivariate and univariate analyses revealed that decreased H/M (d) (<1.7) was the independent predictor of long-term mortality for a variety of causes of death. Although the value of H/M (d) was not a significant prognostic factor for predicting a cardiac event, CAN, diagnosed by a combination of H/M (d) and coefficient variance of RR interval, was an independent predictor for the cardiac event in NIDDM.
CONCLUSION: MIBG myocardial scintigraphy was useful for predicting cardiac events and long-term mortality in NIDDM.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16464715     DOI: 10.1016/j.nuclcard.2005.11.009

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  51 in total

1.  Effects of autonomic neuropathy on coronary blood flow in patients with diabetes mellitus.

Authors:  M F Di Carli; D Bianco-Batlles; M E Landa; A Kazmers; H Groehn; O Muzik; G Grunberger
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

2.  Why does diabetic autonomic neuropathy predict IDDM mortality? An analysis from the Pittsburgh Epidemiology of Diabetes Complications Study.

Authors:  T J Orchard; C E LLoyd; R E Maser; L H Kuller
Journal:  Diabetes Res Clin Pract       Date:  1996-10       Impact factor: 5.602

3.  Prolonged QT interval as a predictor of mortality in diabetic nephropathy.

Authors:  P T Sawicki; R Dähne; R Bender; M Berger
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

4.  Effect of angiotensin-converting enzyme inhibitors on the power spectrum of heart rate variability in post-myocardial infarction patients.

Authors:  A G Kontopoulos; V G Athyros; A A Papageorgiou; V M Skeberis; E C Basayiannis; H Boudoulas
Journal:  Coron Artery Dis       Date:  1997 Aug-Sep       Impact factor: 1.439

Review 5.  Diabetic autonomic neuropathy.

Authors:  Aaron I Vinik; Roy Freeman; Tomris Erbas
Journal:  Semin Neurol       Date:  2003-12       Impact factor: 3.420

Review 6.  Preventing heart failure in patients with diabetes.

Authors:  Preethi Srikanthan; Willa Hsueh
Journal:  Med Clin North Am       Date:  2004-09       Impact factor: 5.456

7.  Myocardial imaging with a radioiodinated norepinephrine storage analog.

Authors:  D M Wieland; L E Brown; W L Rogers; K C Worthington; J L Wu; N H Clinthorne; C A Otto; D P Swanson; W H Beierwaltes
Journal:  J Nucl Med       Date:  1981-01       Impact factor: 10.057

8.  Abnormal I-123 metaiodobenzylguanidine myocardial washout and distribution may reflect myocardial adrenergic derangement in patients with congestive cardiomyopathy.

Authors:  E B Henderson; J K Kahn; J R Corbett; D E Jansen; J J Pippin; P Kulkarni; V Ugolini; M S Akers; C Hansen; L M Buja
Journal:  Circulation       Date:  1988-11       Impact factor: 29.690

9.  Prognostic implications of an initial loss of cardiac metaiodobenzylguanidine uptake and diabetes mellitus in patients with left ventricular dysfunction.

Authors:  Tomoaki Nakata; Takeru Wakabayashi; Michifumi Kyuma; Tohru Takahashi; Akiyoshi Hashimoto; Hitoko Ogata; Kazufumi Tsuchihashi; Kazuaki Shimamoto
Journal:  J Card Fail       Date:  2003-04       Impact factor: 5.712

10.  Noninvasive detection of cardiac sympathetic nervous dysfunction in diabetic patients using [123I]metaiodobenzylguanidine.

Authors:  M Mäntysaari; J Kuikka; J Mustonen; K Tahvanainen; E Vanninen; E Länsimies; M Uusitupa
Journal:  Diabetes       Date:  1992-09       Impact factor: 9.461

View more
  23 in total

1.  Assessment of global cardiac I-123 MIBG uptake and washout using volumetric quantification of SPECT acquisitions.

Authors:  Berlinda J van der Veen; Imad Al Younis; Albert de Roos; Marcel P M Stokkel
Journal:  J Nucl Cardiol       Date:  2012-06-06       Impact factor: 5.952

Review 2.  Radionuclide imaging of cardiac autonomic innervation.

Authors:  Sang Yong Ji; Mark I Travin
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

3.  Heart rate response during vasodilator stress myocardial perfusion imaging: Mechanisms and implications.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2010-08       Impact factor: 5.952

4.  I-123 metaiodobenzylguanidine imaging in non-insulin-dependent diabetic patients with normal myocardial perfusion scans: new insights into their increased cardiac morbidity and mortality rates.

Authors:  Nauman Mushtaq; Myron C Gerson
Journal:  J Nucl Cardiol       Date:  2006 Jan-Feb       Impact factor: 5.952

Review 5.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

Review 6.  Cardiovascular imaging in diabetes mellitus.

Authors:  Fadi G Hage; Ami E Iskandrian
Journal:  J Nucl Cardiol       Date:  2011-10       Impact factor: 5.952

Review 7.  The Type 2 Diabetic Heart: Its Role in Exercise Intolerance and the Challenge to Find Effective Exercise Interventions.

Authors:  J Chris Baldi; Genevieve A Wilson; Luke C Wilson; Gerard T Wilkins; Regis R Lamberts
Journal:  Sports Med       Date:  2016-11       Impact factor: 11.136

Review 8.  Current Clinical Applications and Next Steps for Cardiac Innervation Imaging.

Authors:  Mark I Travin
Journal:  Curr Cardiol Rep       Date:  2017-01       Impact factor: 2.931

9.  ASNC imaging guidelines for SPECT nuclear cardiology procedures: Stress, protocols, and tracers.

Authors:  Milena J Henzlova; W Lane Duvall; Andrew J Einstein; Mark I Travin; Hein J Verberne
Journal:  J Nucl Cardiol       Date:  2016-06       Impact factor: 5.952

10.  New squatting test indices are useful for assessing baroreflex sensitivity in diabetes mellitus.

Authors:  M Nakagawa; T Shinohara; F Anan; K Yufu; N Takahashi; N Okada; M Hara; H Yoshimatsu; T Saikawa
Journal:  Diabet Med       Date:  2008-11       Impact factor: 4.359

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.